HPB Cancer MDT staff

Zahir was appointed Hepatobiliary and Pancreatic Surgeon at Oxford in 2004. He has expanded the range of treatments offered at Oxford with the development of complex minimally-invasive procedures such as laparoscopic and robotic liver resection and pancreatectomy. He is the Clinical Director for General Surgery, having previously been the Deputy Divisional Medical Director. These roles provide oversight of the quality of care provided to all patients across the department.

Zahir has an interest in theatre performance and chairs the Robotic Surgery Steering Committee at the Churchill Hospital. He has chaired the Neuroendocrine Tumour (NET) MDT at Oxford and, in addition to liver and pancreatic surgery, has a special interest in surgery for neuroendocrine tumours.

His national roles include regional representative on the council of the Association of Upper GI Surgeons (AUGIS) and member of the Clinical Practice Committee of the UK and Ireland Neuroendocrine Tumour Society.

Michael was appointed Consultant Hepatobiliary and Pancreatic Surgeon in 2009. He is Clinical Lead for the department and previously was chair of the liver cancer MDT (2012-2020). He introduced minimal access laparoscopic liver surgery to Oxford and is a robotic HPB surgeon. He has a special interest in the treatment of cholangiocarcinoma and bile duct injuries sustained at surgery. Michael is the Oxford lead for the national programme offering total pancreatectomy and islet auto-transplantation for a select group of patients with chronic pancreatitis.

He completed higher surgical and specialist HPB training the West Midlands and obtained a MD in 2007 following research into the effects of ischaemic injury caused to the liver during surgery and transplantation from the University of Birmingham.

Michael is the training programme director for higher surgical trainees (general surgery) in the Oxford Deanery. He is a member of council of the Royal College of Surgeons of Edinburgh and was director of the surgical advisory network in the UK for the College (2018-2022). He is a fellow of the faculty of surgical trainers, Royal College of Surgeons of Edinburgh and is also a clinical lecturer at Worcester College, University of Oxford.

Michael was a specialist advisor to the National Institute of Health and Clinical Excellence (NICE) (2018-2021) and served on the editorial board of the British Journal of Surgery (Open) (2015-2021) and Current Surgery Reports. He is a reviewer for many leading scientific journals. He has in excess of 80 publications in international peer reviewed journals and has written many book chapters on his specialty interests.

Venkatesha was appointed Hepatobiliary Pancreatic and Transplant Surgeon in Oxford in 2019. His clinical activities include complex HPB surgery and transplantation (kidney, pancreas, intestines and more recently uterine) along with abdominal multiorgan retrieval surgery. He is joint lead for the national kidney auto transplantation programme.

Venkatesha completed his residency in General Surgery and Surgical Oncology with a focus on HPB surgery from Tata Memorial Hospital, a leading national tertiary referral hospital for comprehensive cancer care at Mumbai, India and completed fellowships in HPB surgery and abdominal multi-visceral transplantation in Dublin and Oxford.

He obtained higher degrees: an MCh from University College Dublin for his research on role of receptor for advanced glycation end products in biliary diseases and an MSc in Healthcare management from Institute of Leadership, Royal College of Surgeons of Ireland.

Venkatesha is a member of several national and international HPB, surgical oncology and transplantation associations and has published in peer-reviewed journals.

Alex was appointed Consultant Hepatobiliary and Pancreatic Surgeon in 2021. His specialist interest is in the management of hepatobiliary malignancy with a particular focus on colorectal liver metastasis and cholangiocarcinoma.

Alex completed a one-year fellowship in advanced liver surgery in Aintree Hospital, Liverpool after having his higher surgical clinical-academic training in Oxford.

He completed a DPhil in Radiation Biology in 2014 and was subsequently appointed as NIHR Academic Clinical Lecturer.

Alex is jointly appointed as a clinical lecturer in hepatobiliary malignancy through the Nuffield Department of Surgical Sciences, University of Oxford. His research interests include the tumour microenvironment, therapy resistance and tumour immunity.

Ramon was appointed consultant medical oncologist in 2022. He has wide experience in the screening, diagnosis and treatment of cancer patients, especially breast and gastrointestinal cancers.

His clinical skills include prescribing and handling oncological therapies (chemotherapy, immunotherapy and targeted therapies) and clinical management of cancer patients and their complications.

Ramon graduated in Medicine from the Federal University of Ceará, in Fortaleza. He completed the CCT equivalent training in Medical Oncology at the Instituto Português de Oncologia do Porto, Portugal, where he had the opportunity to acquire solid experience in different types of malignant tumours, in addition to experience in autologous and heterologous transplantation.

He completed a PhD in Oncology at the University of Porto, Portugal, and a clinical fellowship at the Royal Marsden Hospital, London, UK.

Since 2020, he has been permanent professor of the postgraduate programme in medicine at Universidade Nove de Julho (UNINOVE), São Paulo, Brazil, developing translational research in the area of biomarkers in oncology and pharmacoeconomics. He is leader of the discipline of medical oncology at UNINOVE, where he can exchange experience and contribute to the training of several postgraduate students, in addition to being an effective member of the ethics committee of this university.

Ramon has more than 200 scientific publications in indexed journals, conference proceedings, chapters and books, as well as participating in the editorial board of several international reputed scientific journals.

Jane has been a consultant hepatologist at the John Radcliffe Hospital since 1999, and runs the Hepatology Service, including the Viral Hepatitis Treatment Service and Joint Liver Transplant Clinics.

Jane qualified in medicine from the University of Bristol in 1986. She trained in hepatology in Newcastle, Toronto and Cambridge with an MD from Newcastle in hepatocellular carcinoma. She also manages jaundiced patients with biliary disease.

Emma is a Consultant Hepatologist and Senior Lecturer at the Translational Gastroenterology Unit, John Radcliffe Hospital in Oxford, with an interest in immune mediated liver diseases including IgG4-related disease, autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cholangitis, hepatocellular cancer (HCC) and Cholangiocarcinoma (CCa)

She set up and co-ordinated the IgG4-RD Study in Oxford during her Academic Clinical Fellowship (2010) and Wellcome Trust Clinical Research Fellowship (DPhil 2011-2015). Her PhD work focused on the natural history and immunological drivers of IgG4-RD.

Her NIHR BRC Oxford Clinical Lectureship (2018-) centred on the fibrotic mechanisms of this disease. She runs the Oxford Autoimmune Liver Disease service with specialist IgG4, PSC and autoimmune liver clinics, and runs a regional autoimmune liver disease MDT, and a national Oxford-London IgG4 MDT.

Emma is Chair of UK IgG4 and on the Steering Committee for UK PSC, and a member of the International IgG4-RD, PSC and AIH Study Groups.

Jane qualified in Medicine from the University of Wales College of Medicine in 1986. She then obtained MRCP before undertaking training in Radiology in Cardiff from 1989 to 1995, obtaining FRCR in 1992.

She specialises in hepatobiliary and gastrointestinal interventional radiology, endoscopic ultrasound and ERCP.

Within the Oxford Hepatobiliary and Pancreatic Cancer Multidisciplinary Team, her main roles are in endoscopic ultrasound assessment of pancreatico-biliary disease, drainage of pseudo-cysts, percutaneous and endoscopic insertion of stents for biliary obstruction, and angiography and embolisation for vascular complications of hepatobiliary and pancreatic disease.

Andrew was appointed as a Consultant Interventional Radiologist at Oxford University Hospitals in 2020. He obtained his undergraduate medical degree from Oxford University Medical School in 2009.

He completed four years of surgical training and membership of the Royal College of Surgeons prior to completing Diagnostic and Interventional Radiology training in Oxford and obtaining fellowship of the Royal College of Radiology.

His current clinical and research interests focus on interventional oncology and complex embolisation procedures.

Sue moved to Oxford in 1994 to join the Cancer Research UK research nurse team where she was involved in caring for patients taking part in both early and late phase clinical trials for a number of different types of solid tumours.

Her current role as a senior Specialist Nurse within the Oxford Hepatobiliary MDT is to see and care for patients referred for major and complex pancreatic and liver surgery, and support those who have had a new diagnosis of cancer and may require other non-surgical treatments or chemotherapy.

Working together with her nursing and dietitian colleagues in Oxford and the wider Thames Valley Cancer Network Sue strives to improve the quality of patient experience and helps ensure that a comprehensive service is offered to all patients along the treatment pathway. She has also completed a postgraduate certificate in leadership

'Tash' graduated from the University of Bedfordshire and worked on an emergency surgical ward for two years before volunteering to be redeployed to intensive care during the COVID-19 pandemic.

Tash worked as a Cancer Nurse Specialist in Urology before moving to the HPB team in May 2022 and is studying for a PG Cert in Advanced Cancer Care.

Along with colleagues, Tash supports patients referred to the HPB team who have a new cancer diagnosis or require complex surgery or oncology treatments.

Natasha is a Specialist Dietitian attached to the department of HPB Surgery and works in conjunction with the Clinical Nurse Specialist Team at the Churchill Hospital.

She graduated from the University of Plymouth in 2011 and has been working within the NHS since. She spent two years working in Belfast, Brighton and the Isle of Wight, before moving into a Research Dietitian role at University Hospital Southampton. In 2016 she began working as a Specialist HPB Dietitian (2016-2021), and then progressed to an Advanced Oncology Dietitian at St Richards Hospital in Chichester (2021).

Natasha joined the Oxford HPB team in September 2021 as a Macmillan Specialist HPB Dietitian. She supports patients by giving advice on pancreatic enzyme replacement therapy (PERT), improving fitness for surgery and identifying any nutritional deficits throughout their treatment pathway.